These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 29549729)

  • 61. Folate-modified PLGA nanoparticles for tumor-targeted delivery of pheophorbide a in vivo.
    Son J; Yang SM; Yi G; Roh YJ; Park H; Park JM; Choi MG; Koo H
    Biochem Biophys Res Commun; 2018 Apr; 498(3):523-528. PubMed ID: 29518390
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dual Stable Nanomedicines Prepared by Cisplatin-Crosslinked Camptothecin Prodrug Micelles for Effective Drug Delivery.
    Li Y; Lu H; Liang S; Xu S
    ACS Appl Mater Interfaces; 2019 Jun; 11(23):20649-20659. PubMed ID: 31117440
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Toxicity and therapy of cisplatin-loaded EGF modified mPEG-PLGA-PLL nanoparticles for SKOV3 cancer in mice.
    Wang Y; Liu P; Qiu L; Sun Y; Zhu M; Gu L; Di W; Duan Y
    Biomaterials; 2013 May; 34(16):4068-4077. PubMed ID: 23480957
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer.
    He Y; Huang Y; Huang Z; Jiang Y; Sun X; Shen Y; Chu W; Zhao C
    J Control Release; 2017 Oct; 264():76-88. PubMed ID: 28842315
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Synthesis, characterization and in vivo evaluation of a magnetic cisplatin delivery nanosystem based on PMAA-graft-PEG copolymers.
    Voulgari E; Bakandritsos A; Galtsidis S; Zoumpourlis V; Burke BP; Clemente GS; Cawthorne C; Archibald SJ; Tuček J; Zbořil R; Kantarelou V; Karydas AG; Avgoustakis K
    J Control Release; 2016 Dec; 243():342-356. PubMed ID: 27793687
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Self-assembled targeted nanoparticles based on transferrin-modified eight-arm-polyethylene glycol-dihydroartemisinin conjugate.
    Liu K; Dai L; Li C; Liu J; Wang L; Lei J
    Sci Rep; 2016 Jul; 6():29461. PubMed ID: 27377918
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity.
    Yang F; Li A; Liu H; Zhang H
    Drug Des Devel Ther; 2018; 12():3321-3333. PubMed ID: 30323564
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
    Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
    Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice.
    Abou-ElNaga A; Mutawa G; El-Sherbiny IM; Abd-ElGhaffar H; Allam AA; Ajarem J; Mousa SA
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417924
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.
    Khan MW; Zhao P; Khan A; Raza F; Raza SM; Sarfraz M; Chen Y; Li M; Yang T; Ma X; Xiang G
    Int J Nanomedicine; 2019; 14():3753-3771. PubMed ID: 31239661
    [No Abstract]   [Full Text] [Related]  

  • 71. Fabrication and evaluation of a γ-PGA-based self-assembly transferrin receptor-targeting anticancer drug carrier.
    Zhang L; Zhu X; Wu S; Chen Y; Tan S; Liu Y; Jiang W; Huang J
    Int J Nanomedicine; 2018; 13():7873-7889. PubMed ID: 30538465
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
    Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
    Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer.
    Liu B; Han L; Liu J; Han S; Chen Z; Jiang L
    Int J Nanomedicine; 2017; 12():955-968. PubMed ID: 28203075
    [TBL] [Abstract][Full Text] [Related]  

  • 74. pH sensitive polymeric complex of cisplatin with hyaluronic acid exhibits tumor-targeted delivery and improved in vivo antitumor effect.
    Fan X; Zhao X; Qu X; Fang J
    Int J Pharm; 2015 Dec; 496(2):644-53. PubMed ID: 26529576
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Preparation of folate-targeted magnetic nanocomposites loaded with TFPI-2 plasmid and cisplatin and evaluation of its targeting and inhibitory effect on nasopharyngeal carcinoma HNE-1 cells in vitro].
    Liu RZ; Zhang J; Liu T; Fu XY; Zhang LM; Xie MQ
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(25):2023-30. PubMed ID: 27470963
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Functionalized milk-protein-coated magnetic nanoparticles for MRI-monitored targeted therapy of pancreatic cancer.
    Huang J; Qian W; Wang L; Wu H; Zhou H; Wang AY; Chen H; Yang L; Mao H
    Int J Nanomedicine; 2016; 11():3087-99. PubMed ID: 27462153
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antitumor effect of poly lactic acid nanoparticles loaded with cisplatin and chloroquine on the oral squamous cell carcinoma.
    Li Q; Liu X; Yan W; Chen Y
    Aging (Albany NY); 2020 Dec; 13(2):2593-2603. PubMed ID: 33323546
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice.
    Nishiyama N; Okazaki S; Cabral H; Miyamoto M; Kato Y; Sugiyama Y; Nishio K; Matsumura Y; Kataoka K
    Cancer Res; 2003 Dec; 63(24):8977-83. PubMed ID: 14695216
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The therapeutic effect and MR molecular imaging of FA-PEG-FePt/DDP nanoliposomes in AMF on ovarian cancer.
    Bian X; Guo T; Chen G; Nie D; Yue M; Zhu Y; Lin M
    Int J Nanomedicine; 2024; 19():5227-5243. PubMed ID: 38855734
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Preparation and evaluation of a novel liposomal formulation of cisplatin.
    Zhou X; Wang J; Wu J; Yang X; Yung BC; Lee LJ; Lee RJ
    Eur J Pharm Sci; 2015 Jan; 66():90-5. PubMed ID: 25446511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.